Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.52 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.50 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | CTSG | P08311 | 1/20 | 0.50 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.50 |
| ▸ | CMA1 | P23946 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21258119 | 0.89 | EPHX2 (0.57) | LMNAHPGDALDH1A1POLBNPC1 | |
| SCHEMBL28176032 | 0.83 | KMT2A (0.53) | GAALMNAHPGDALDH1A1SMN1; SMN2 | |
| SCHEMBL3192014 | 0.82 | LMNA (0.77) | GAALMNAHPGDPOLBNPC1 | |
| SCHEMBL9769939 | 0.82 | GAA (0.61) | GAALMNAHPGDALDH1A1POLB | |
| SCHEMBL83922 | 0.82 | HPGD (0.86) | GAALMNAHPGDALDH1A1POLB | |
| SCHEMBL18689914 | 0.81 | LMNA (0.69) | GAALMNAHPGDPOLBNPC1 | |
| SCHEMBL27567042 | 0.80 | GAA (0.59) | GAALMNAHPGDALDH1A1POLB | |
| SCHEMBL28007671 | 0.80 | LMNA (0.62) | GAALMNAHPGDPOLBNPC1 | |
| SCHEMBL9603067 | 0.80 | GAA (0.59) | GAALMNAHPGDALDH1A1POLB | |
| SCHEMBL9665775 | 0.80 | GAA (0.59) | GAALMNAHPGDALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116251225-B | Developing embolism microsphere and processing method thereof | 科睿驰（深圳）医疗科技发展有限公司 | 2025-04-22 | — | — | CN | claimed |
| CN-116251225-A | Developing embolism microsphere and processing method thereof | 科睿驰（深圳）医疗科技发展有限公司 | 2023-06-13 | — | — | CN | claimed |
| EP-0998946-A1 | Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2000-05-10 | — | — | EP | claimed |
| WO-2000009169-A1 | NON-PORPHYRIN COMPOUND FOR USE AS A DIAGNOSTICUM AND/OR PHARMACEUTICAL | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 2000-02-24 | — | — | WO | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| CN-116251225-B | Developing embolism microsphere and processing method thereof | 科睿驰（深圳）医疗科技发展有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-116251225-A | Developing embolism microsphere and processing method thereof | 科睿驰（深圳）医疗科技发展有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-105732414-B | The method of control of amide derivatives, the noxious organism control agent containing the amide derivatives and harmful organism | 三井化学AGRO株式会社 | 2019-05-03 | — | — | CN | disclosed |
| WO-2017143059-A1 | MAX BINDERS AS MYC MODULATORS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-08-24 | — | — | WO | disclosed |
| EP-2409569-B1 | Method for administering GLP-1 molecules | EMISPHERE TECH INC (US) | 2017-08-16 | — | — | EP | disclosed |
| US-9234000-B2 | Benzylamine derivatives as inhibitors of plasma kallikrein | KALVISTA PHARMACEUTICALS LIMITED (GB) | 2016-01-12 | — | — | US | disclosed |
| US-9234000-B2 | Benzylamine derivatives as inhibitors of plasma kallikrein | KALVISTA PHARMACEUTICALS LIMITED (GB) | 2016-01-12 | — | — | US | disclosed |
| US-5658908-A | RECEPTOR BINDING SPECIES FOR MEDIATING ANALGESIA, COMBATTING DRUG ADDICTION, DRUG OVERDOSE | DELTA PHARMACEUTICALS, INC. (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
| EP-0115227-B1 | PEPTIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1987-03-18 | — | — | EP | disclosed |
| US-4530837-A | Containing tryptophan | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1985-07-23 | — | — | US | disclosed |
| EP-0115227-A1 | Peptide derivatives, process for their preparation and their pharmaceutical use | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1984-08-08 | — | — | EP | disclosed |
| US-4164571-A | Medicament which antagonizes the action of gastrin and related polypeptides | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1979-08-14 | — | — | US | disclosed |